<p>Cardiol Therapeutics Inc. (TSE:CRDL - 获取免费报告) 的股价在周二的午盘交易中下跌了 0.7%。该公司的股价最低曾达到 C$1.37，最后交易价为 C$1.39。在午盘交易中，共交易了 25,955 股，较平均交易量 107,933 股下降了 76%。该股票此前收盘价为 C$1.40。</p>
<p>获取 <strong>Cardiol Therapeutics</strong> 的提醒：</p>
<h2>Cardiol Therapeutics 股票表现</h2>
<p>该公司的市值为 1.39 亿加元，市盈率为-3.39，贝塔系数为 1.55。该股票的 50 日简单移动平均线为 C$1.47，200 日简单移动平均线为 C$1.61。该公司的速动比率为 6.84，流动比率为 2.49，债务与股本比率为 1.59。</p>
<p>Cardiol Therapeutics (TSE:CRDL - 获取免费报告) 最近于 11 月 13 日（星期四）发布了季度财报。该公司报告本季度每股收益为 C($0.12)。整体来看，研究分析师预计 Cardiol Therapeutics Inc.在当前年度的每股收益将为-0.49。</p>
<h2>Cardiol Therapeutics 公司简介</h2>
<p>(获取免费报告)</p>
<p>Cardiol Therapeutics Inc NASDAQ: CRDLTSX: CRDL 是一家临床阶段的生命科学公司，专注于心脏病的抗炎和抗纤维化疗法的研究与临床开发。公司的主要药物候选者 CardiolRxTM（大麻二酚）口服溶液，经过药品制造，正在进行临床开发以用于心脏病治疗。已知大麻二酚能够抑制炎症小体通路的激活，这一细胞内过程在与心肌炎、心包炎和心力衰竭相关的炎症和纤维化的发展与进展中起着重要作用。</p>
<h2>相关文章</h2>
<ul>
<li>我们更看好的五只股票超过 Cardiol Therapeutics</li>
<li>可能每月支付高达$4,290 的无聊 AI 投资</li>
<li>在 1 月 1 日之前投资$1,000 于这只股票 [不是 NVDA]</li>
<li>特朗普的 “美国房地产交易” 解释</li>
<li>崩盘前一个月</li>
<li>特朗普做了什么？？</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 于 Cardiol Therapeutics 吗？</h2>
<p>在考虑 Cardiol Therapeutics 之前，你需要听听这个。</p>
<p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每日推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄推荐给客户的股票，以便在更广泛的市场注意到之前购买……而 Cardiol Therapeutics 并不在名单上。</p>
<p>虽然 Cardiol Therapeutics 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

CRDL

<p>Cardiol Therapeutics Inc.（多伦多证券交易所代码：CRDL）在周二的午盘交易中，股价下跌了 0.7%，至 1.39 加元，交易量显著下降。该公司的市值为 1.39 亿加元，专注于开发针对心脏病的抗炎和抗纤维化疗法。尽管分析师给予了持有评级，但 Cardiol Therapeutics 并未被 MarketBeat 的顶级分析师推荐为前五大股票</p>

<p>Cardiol Therapeutics Inc. (TSE:CRDL - Get Free Report)'s share price traded down 0.7% during mid-day trading on Tuesday . The company traded as low as C$1.37 and last traded at C$1.39. 25,955 shares were traded during mid-day trading, a decline of 76% from the average session volume of 107,933 shares. The stock had previously closed at C$1.40.</p>
<div class="lb-trans"><p>Cardiol Therapeutics Inc. (TSE:CRDL - 获取免费报告) 的股价在周二的午盘交易中下跌了 0.7%。该公司的股价最低曾达到 C$1.37，最后交易价为 C$1.39。在午盘交易中，共交易了 25,955 股，较平均交易量 107,933 股下降了 76%。该股票此前收盘价为 C$1.40。</p>
</div><p>Get <strong>Cardiol Therapeutics</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Cardiol Therapeutics</strong> 的提醒：</p>
</div><h2>Cardiol Therapeutics Stock Performance</h2>
<div class="lb-trans"><h2>Cardiol Therapeutics 股票表现</h2>
</div><p>The company has a market cap of C$139.00 million, a PE ratio of -3.39 and a beta of 1.55. The stock's 50 day simple moving average is C$1.47 and its two-hundred day simple moving average is C$1.61. The company has a quick ratio of 6.84, a current ratio of 2.49 and a debt-to-equity ratio of 1.59.</p>
<div class="lb-trans"><p>该公司的市值为 1.39 亿加元，市盈率为-3.39，贝塔系数为 1.55。该股票的 50 日简单移动平均线为 C$1.47，200 日简单移动平均线为 C$1.61。该公司的速动比率为 6.84，流动比率为 2.49，债务与股本比率为 1.59。</p>
</div><p>Cardiol Therapeutics (TSE:CRDL - Get Free Report) last released its quarterly earnings data on Thursday, November 13th. The company reported C($0.12) EPS for the quarter. As a group, research analysts anticipate that Cardiol Therapeutics Inc. will post -0.49 earnings per share for the current year.</p>
<div class="lb-trans"><p>Cardiol Therapeutics (TSE:CRDL - 获取免费报告) 最近于 11 月 13 日（星期四）发布了季度财报。该公司报告本季度每股收益为 C($0.12)。整体来看，研究分析师预计 Cardiol Therapeutics Inc.在当前年度的每股收益将为-0.49。</p>
</div><h2>Cardiol Therapeutics Company Profile</h2>
<div class="lb-trans"><h2>Cardiol Therapeutics 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Cardiol Therapeutics Inc NASDAQ: CRDLTSX: CRDL is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure.</p>
<div class="lb-trans"><p>Cardiol Therapeutics Inc NASDAQ: CRDLTSX: CRDL 是一家临床阶段的生命科学公司，专注于心脏病的抗炎和抗纤维化疗法的研究与临床开发。公司的主要药物候选者 CardiolRxTM（大麻二酚）口服溶液，经过药品制造，正在进行临床开发以用于心脏病治疗。已知大麻二酚能够抑制炎症小体通路的激活，这一细胞内过程在与心肌炎、心包炎和心力衰竭相关的炎症和纤维化的发展与进展中起着重要作用。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>相关文章</h2>
</div><ul>
<li>Five stocks we like better than Cardiol Therapeutics</li>
<li>The boring AI play that could pay up to $4,290 monthly</li>
<li>Put $1,000 into this stock by Jan 1 [Not NVDA]</li>
<li>Trump’s “real estate deal for America” explained</li>
<li>A month before the crash</li>
<li>Trump Did WHAT??</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 Cardiol Therapeutics</li>
<li>可能每月支付高达$4,290 的无聊 AI 投资</li>
<li>在 1 月 1 日之前投资$1,000 于这只股票 [不是 NVDA]</li>
<li>特朗普的 “美国房地产交易” 解释</li>
<li>崩盘前一个月</li>
<li>特朗普做了什么？？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cardiol Therapeutics Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 于 Cardiol Therapeutics 吗？</h2>
</div><p>Before you consider Cardiol Therapeutics, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Cardiol Therapeutics 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardiol Therapeutics wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每日推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄推荐给客户的股票，以便在更广泛的市场注意到之前购买……而 Cardiol Therapeutics 并不在名单上。</p>
</div><p>While Cardiol Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Cardiol Therapeutics 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Cardiol Therapeutics (TSE:CRDL) 股价下跌 0.7% - 以下是原因